2-162147348-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_002054.5(GCG):c.254+5G>A variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00585 in 1,610,428 control chromosomes in the GnomAD database, including 60 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 56 hom. )
Consequence
GCG
NM_002054.5 splice_region, intron
NM_002054.5 splice_region, intron
Scores
2
Splicing: ADA: 0.9996
2
Clinical Significance
Conservation
PhyloP100: 5.51
Genes affected
GCG (HGNC:4191): (glucagon) The protein encoded by this gene is actually a preproprotein that is cleaved into four distinct mature peptides. One of these, glucagon, is a pancreatic hormone that counteracts the glucose-lowering action of insulin by stimulating glycogenolysis and gluconeogenesis. Glucagon is a ligand for a specific G-protein linked receptor whose signalling pathway controls cell proliferation. Two of the other peptides are secreted from gut endocrine cells and promote nutrient absorption through distinct mechanisms. Finally, the fourth peptide is similar to glicentin, an active enteroglucagon. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 2-162147348-C-T is Benign according to our data. Variant chr2-162147348-C-T is described in ClinVar as [Benign]. Clinvar id is 711801.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.00609 (8886/1458166) while in subpopulation EAS AF= 0.0239 (946/39630). AF 95% confidence interval is 0.0226. There are 56 homozygotes in gnomad4_exome. There are 4581 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCG | NM_002054.5 | c.254+5G>A | splice_region_variant, intron_variant | ENST00000418842.7 | NP_002045.1 | |||
LOC101929532 | NR_110255.1 | n.93-14422C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCG | ENST00000418842.7 | c.254+5G>A | splice_region_variant, intron_variant | 1 | NM_002054.5 | ENSP00000387662.2 | ||||
GCG | ENST00000375497.3 | c.254+5G>A | splice_region_variant, intron_variant | 5 | ENSP00000364647.3 | |||||
GCG | ENST00000492913.1 | n.343+5G>A | splice_region_variant, intron_variant | 2 | ||||||
GCG | ENST00000497568.1 | n.41+5G>A | splice_region_variant, intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00353 AC: 537AN: 152144Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
537
AN:
152144
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00550 AC: 1364AN: 247922Hom.: 8 AF XY: 0.00600 AC XY: 807AN XY: 134452
GnomAD3 exomes
AF:
AC:
1364
AN:
247922
Hom.:
AF XY:
AC XY:
807
AN XY:
134452
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00609 AC: 8886AN: 1458166Hom.: 56 Cov.: 30 AF XY: 0.00632 AC XY: 4581AN XY: 725318
GnomAD4 exome
AF:
AC:
8886
AN:
1458166
Hom.:
Cov.:
30
AF XY:
AC XY:
4581
AN XY:
725318
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00355 AC: 540AN: 152262Hom.: 4 Cov.: 32 AF XY: 0.00335 AC XY: 249AN XY: 74432
GnomAD4 genome
AF:
AC:
540
AN:
152262
Hom.:
Cov.:
32
AF XY:
AC XY:
249
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
56
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at